|
|
Volumn 3, Issue 4, 2005, Pages 121-125
|
|
Osteoprotegerin as a potential therapy for osteoporosis.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BONE DENSITY CONSERVATION AGENT;
CARRIER PROTEIN;
CELL RECEPTOR;
DENOSUMAB;
GLYCOPROTEIN;
MEMBRANE PROTEIN;
MONOCLONAL ANTIBODY;
OSTEOCLAST DIFFERENTIATION FACTOR;
OSTEOPROTEGERIN;
RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B;
TNFRSF11A PROTEIN, HUMAN;
TNFRSF11B PROTEIN, HUMAN;
TNFSF11 PROTEIN, HUMAN;
TUMOR NECROSIS FACTOR RECEPTOR;
ANIMAL;
HUMAN;
OSTEOLYSIS;
OSTEOPOROSIS;
PATHOPHYSIOLOGY;
PHYSIOLOGY;
POSTMENOPAUSE OSTEOPOROSIS;
REVIEW;
SIGNAL TRANSDUCTION;
ANIMALS;
ANTIBODIES, MONOCLONAL;
BONE DENSITY CONSERVATION AGENTS;
BONE RESORPTION;
CARRIER PROTEINS;
GLYCOPROTEINS;
HUMANS;
MEMBRANE GLYCOPROTEINS;
OSTEOPOROSIS;
OSTEOPOROSIS, POSTMENOPAUSAL;
OSTEOPROTEGERIN;
RANK LIGAND;
RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B;
RECEPTORS, CYTOPLASMIC AND NUCLEAR;
RECEPTORS, TUMOR NECROSIS FACTOR;
SIGNAL TRANSDUCTION;
|
|
EID: 33645272569
PISSN: 15441873
EISSN: None
Source Type: Journal
DOI: 10.1007/s11914-996-0014-5 Document Type: Review |
|
Times cited : (14)
|
|
References (50)
|
